1. Home
  2. FA vs IDYA Comparison

FA vs IDYA Comparison

Compare FA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$20.27

Market Cap

3.5B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$35.48

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
IDYA
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
FA
IDYA
Price
$20.27
$35.48
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$15.67
$52.86
AVG Volume (30 Days)
1.8M
851.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
61.90
EPS
0.01
N/A
Revenue
$1,574,389,000.00
$218,710,000.00
Revenue This Year
$8.42
N/A
Revenue Next Year
$7.26
$201.05
P/E Ratio
$2,039.00
N/A
Revenue Growth
83.02
3024.43
52 Week Low
$8.82
$22.09
52 Week High
$22.78
$40.58

Technical Indicators

Market Signals
Indicator
FA
IDYA
Relative Strength Index (RSI) 52.00 52.91
Support Level $19.05 $33.23
Resistance Level $20.97 $38.11
Average True Range (ATR) 0.95 1.40
MACD -0.25 -0.25
Stochastic Oscillator 26.91 54.24

Price Performance

Historical Comparison
FA
IDYA

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: